Navigation Links
Plaintiff Furnishes Witness List for First Trial in DePuy ASR Multidistrict Litigation, Reports Parker Waichman LLP
Date:8/15/2013

(PRWEB) August 15, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, reports that, based on a document filed on Aug. 12, 2013, in the District Court, Northern District of Ohio, the Plaintiff in the first bellwether case in the lawsuit entitled: In Re DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation (MDL 2197) has identified 95 witnesses who could be called to testify on her behalf. The trial is slated to begin on Sept. 9, 2013 (McCracken v. DePuy Orthopaedics Inc., et al., Case No. 1:11-dp-20485).

Plaintiff Ann McCracken was implanted with the DePuy ASR metal hip on or around Aug. 24, 2009, and alleges that, as a result of the procedure, she suffered and continues to suffer serious bodily injury and was forced to undergo revision surgery on or around Jan. 17, 2011, according to court documents. McCracken resides in Rochester, New York.

“Considering the kinds of injuries these metal-on-metal hip implants are alleged to have caused, it is important that we continue moving forward,” said Daniel C. Burke, Senior Litigation Counsel at Parker Waichman LLP.

According to information posted on Jan. 17, 2013, by the U.S. Food and Drug Administration(FDA), those with metal hip implants may experience adverse events after surgery, including:

  •     Hip dislocation, when the ball of the thighbone (femur) slips out of its socket in the hip bone (pelvis)
  •     Bone fracture
  •     Joint infection
  •     Local nerve damage with numbness/weakness
  •     Device loosening or breakage
  •     Difference in leg lengths
  •     Bone loss (osteolysis)

The FDA also noted that patients should be aware of potential symptoms that may occur three or more months after surgery, including:

  •     Pain in the groin, hip or leg
  •     Swelling at or near the hip joint
  •     A limp or change in walking ability
  •     Noise (popping, grinding, clicking or squeaking) from the hip joint

DePuy’s ASR and other metal-on-metal hip implants were approved via the 510(k) route, which exempts devices from clinical testing as long as the manufacturers show that their product is similar to a previous device already on the market. The FDA reported on Jan. 18, 2013, that it was attempting to change the 510(k) approval process; the agency has proposed that all-metal hip replacements go through premarket approval, which would require device makers to prove that their products are safe and effective.

A March 8, 2013, Bloomberg article noted that Johnson & Johnson, DePuy’s parent company, recalled 93,000 ASR hips in 2010, citing a failure rate of 12 percent in five years. In Australia, failure rates have exceeded 40 percent in seven years, Bloomberg reported.

Parker Waichman LLP continues to offer free legal consultations to victims of injuries allegedly caused by DePuy ASR and other metal-on-metal hip implants. If you or a loved one experienced premature failure of your implant or other health problems associated with a recalled DePuy ASR hip implant or other metal-on-metal hip implant, please contact their office by visiting the firm's DePuy ASR hip implant injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
yourlawyer.com

Read the full story at http://www.prweb.com/releases/DePuyASR_McCracken/08/prweb11032815.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
2. US Drug Watchdog Now Offers Victims Of A Transvaginal Mesh Product Failure A Unequaled Service By Offering the Names of Top Plaintiffs Attorneys-Who are all also Women
3. Skechers Lawsuit Filed by Wright & Schulte, Utah Plaintiff Allegedly Suffered Serious Ankle Injuries Due to Shape-Ups Defective Design
4. US Drug Watchdog Now Urges Transvaginal Mesh, Tape, or Bladder Sling Failure Victims To Call Them For the Names of Top Plaintiffs Women Attorneys--Erosion Is Not Normal
5. Skechers Lawsuit Filed On Behalf of Ohio Woman, Alleging That the Defective Design of Shape-Ups Caused the Plaintiff’s Serious Knee Injuries, by Wright & Schulte
6. Skechers Injury Lawsuit Update: Richard W. Schulte, Partner with Wright & Schulte LLC, Appointed to Plaintiffs’ Steering Committee in California Skechers Toning Shoes Litigation
7. Imprelis Class Action Lawsuit Plaintiffs Could See Settlement Soon, Clients Can Opt-Out If Settlement Is Insufficient, Reports Wright & Sculte LLC
8. NuvaRing Lawsuits Move Forward, as Federal Judge Rules that Plaintiffs’ Experts May Testify on “Bursts” of Estrogen Allegedly Delivered by NuvaRing, Wright & Schulte LLC
9. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
10. Mirena IUD Lawyers at Gilman Law LLP, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Anticipates Progress in Newly Established Mirena Federal Litigation
11. Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
Breaking Medicine Technology: